New app aims to ease symptoms for young cancer survivors

NCT ID NCT05748210

Recruiting now Symptom relief Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a mobile app designed to help children aged 9 to 16 who have recently finished cancer treatment manage their symptoms. The app provides educational materials and real-time support, plus personalized help from a nurse. Researchers want to see if using the app for 12 weeks improves children's physical function, anxiety, depression, fatigue, peer relationships, and pain, and also boosts their caregivers' quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: symptom management mobile health application with personalised nurse support
What this could lead to: If it works, this app could provide a practical, low-cost way to help children recovering from cancer feel better physically and emotionally, and improve their caregivers' quality of life.
What could go wrong: This is a relatively small, early-stage trial testing a behavioural intervention, so results may not apply broadly. The app's benefits depend on consistent use and may not be dramatic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ONCOLOGY SURVIVORSHIP

Contacts and locations

Locations

The Chinese University of Hong Kong
NOT_YET_RECRUITING

Hong Kong, Hong Kong
The Chinese University of Hong Kong
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.